Balance Sheet Okamura Corporation

Equities

7994

JP3192400004

Business Support Supplies

Delayed Japan Exchange Other stock markets 02:30:00 2025-06-18 am EDT			5-day change	1st Jan Change
2,201.00 ^JPY	+0.27%		+0.18%	+6.69%

May. 09	Okamura Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2026	CI
Mar. 25	Okamura to Acquire UK-based Boss Design	MT

47fd2dfe4cddace01bb3eec45c0.egW8HMYGhEZ6wQvtSuctF1L1YnTwN17YBwNmmdxWZbE.TF-NXpNC4QxIrE6EJYpHOjC2IDjCUBWPaVo-95cRKuUtNP1k8kHoARX4fA

Published financial data: OKAMURA CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	253B	244B	261B	277B	298B
Total Revenues	253B	244B	261B	277B	298B
Cost of Goods Sold, Total	171B	164B	178B	188B	199B
Gross Profit	81.75B	80.11B	83.59B	89B	99.77B
Selling General & Admin Expenses, Total	66.08B	63.54B	65.43B	69.26B	73.39B
Depreciation & Amortization - (IS)	2.28B	2.4B	2.18B	2.37B	2.35B
Other Operating Expenses, Total	68.36B	65.94B	67.61B	71.63B	75.74B
Operating Income	13.39B	14.18B	15.97B	17.37B	24.04B
Interest Expense, Total	-163M	-163M	-151M	-180M	-153M
Interest And Investment Income	923M	907M	888M	926M	1.01B
Net Interest Expenses	760M	744M	737M	746M	855M
Income (Loss) On Equity Invest.	360M	193M	395M	469M	510M
Currency Exchange Gains (Loss)	-115M	-	374M	339M	182M
Other Non Operating Income (Expenses)	410M	543M	293M	379M	813M
EBT, Excl. Unusual Items	14.81B	15.66B	17.77B	19.31B	26.4B
Gain (Loss) On Sale Of Investments	-297M	2.34B	3.9B	4.34B	3.37B
Gain (Loss) On Sale Of Assets	181M	154M	-283M	-382M	-171M
Asset Writedown	-206M	-41M	-76M	-143M	-35M
Other Unusual Items	-2M	-102M	357M	24M	-1M
EBT, Incl. Unusual Items	14.48B	18.01B	21.67B	23.15B	29.56B
Income Tax Expense	4.6B	6.06B	6.59B	6.94B	8.93B
Earnings From Continuing Operations	9.88B	11.95B	15.07B	16.21B	20.63B
Net Income to Company	9.88B	11.95B	15.07B	16.21B	20.63B
Minority Interest	-31M	21M	-82M	-307M	-348M
Net Income - (IS)	9.85B	11.97B	14.99B	15.91B	20.28B
Net Income to Common Incl Extra Items	9.85B	11.97B	14.99B	15.91B	20.28B
Net Income to Common Excl. Extra Items	9.85B	11.97B	14.99B	15.91B	20.28B
Per Share Items
Net EPS - Basic	89.44	112.5	151.25	163.14	214.27
Basic EPS - Continuing Operations	89.44	112.5	151.25	163.14	214.27
Basic Weighted Average Shares Outstanding	110M	106M	99.12M	97.5M	94.65M
Net EPS - Diluted	89.44	112.5	151.25	163.14	214.27
Diluted EPS - Continuing Operations	89.44	112.5	151.25	163.14	214.27
Diluted Weighted Average Shares Outstanding	110M	106M	99.12M	97.5M	94.65M
Normalized Basic EPS	83.73	92.16	111.23	120.61	170.64
Normalized Diluted EPS	83.73	92.16	111.23	120.61	170.64
Dividend Per Share	32	32	40	55	86
Payout Ratio	33.59	25.8	26.63	25.85	35.47
Supplemental Items
EBITDA	19.32B	20.18B	21.71B	23.59B	30.57B
EBITA	13.39B	14.18B	15.97B	17.37B	24.04B
EBIT	13.39B	14.18B	15.97B	17.37B	24.04B
EBITDAR	28.37B	28.94B	29.57B	32.64B	39.46B
Effective Tax Rate - (Ratio)	31.76	33.64	30.43	29.96	30.21
Normalized Net Income	9.22B	9.81B	11.03B	11.76B	16.15B
Non-Cash Pension Expense	321M	-33M	81M	237M	-195M
Supplemental Operating Expense Items
Selling and Marketing Expenses	14.2B	12.39B	12.42B	12.12B	12.9B
Research And Development Expense From Footnotes	1.16B	1.23B	1.26B	1.12B	1.49B
Net Rental Expense, Total	9.04B	8.76B	7.86B	9.06B	8.89B
Imputed Operating Lease Interest Expense	528M	521M	439M	610M	518M
Imputed Operating Lease Depreciation	8.51B	8.24B	7.43B	8.45B	8.37B

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	32.59B	45.16B	39.95B	38.53B	39.17B
Short Term Investments	510M	10M	-	491M	-
Total Cash And Short Term Investments	33.1B	45.17B	39.95B	39.02B	39.17B
Accounts Receivable, Total	71.55B	66.81B	68.77B	73.41B	81.26B
Total Receivables	71.55B	66.81B	68.77B	73.41B	81.26B
Inventory	18.14B	14.8B	20.65B	21.16B	21.35B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	2.01B	2.54B	2.64B	3.84B	3.21B
Total Current Assets	125B	129B	132B	137B	145B
Net Property Plant And Equipment	58.1B	58.24B	59.52B	66.35B	76.77B
Long-term Investments	48.57B	54.35B	48.08B	43.68B	54.08B
Goodwill	-	-	2.41B	2.16B	2.53B
Other Intangibles, Total	3.76B	3.38B	3.14B	3.05B	3.38B
Deferred Tax Assets Long-Term	1.1B	184M	216M	222M	366M
Other Long-Term Assets, Total	3M	2M	3M	2M	2M
Total Assets	236B	245B	245B	253B	282B
Liabilities
Accounts Payable, Total	43.17B	44.86B	40.54B	40.51B	42.87B
Accrued Expenses, Total	4.42B	3.93B	4.36B	4.25B	6.24B
Short-term Borrowings	6.24B	6.11B	6.07B	6.31B	6.19B
Current Portion of Long-Term Debt	2.55B	1.67B	5.69B	1.19B	5.2B
Current Income Taxes Payable	6.02B	6.72B	6.5B	6.15B	8.44B
Other Current Liabilities	5B	5.68B	7.11B	8.06B	7.35B
Total Current Liabilities	67.41B	68.97B	70.27B	66.47B	76.29B
Long-Term Debt	13.34B	13.94B	9.83B	13.65B	9.47B
Pension & Other Post Retirement Benefits	15.57B	15.91B	15.94B	15.17B	14.31B
Deferred Tax Liability Non Current	408M	2.74B	887M	727M	3.26B
Other Non Current Liabilities	4.1B	4.14B	4.32B	4.2B	4B
Total Liabilities	101B	106B	101B	100B	107B
Common Stock, Total	18.67B	18.67B	18.67B	18.67B	18.67B
Additional Paid In Capital	16.77B	16.77B	16.77B	16.77B	16.77B
Retained Earnings	92.53B	90.24B	100B	112B	125B
Treasury Stock	-2.44B	-110M	-3.63B	-7.71B	-7.72B
Comprehensive Income and Other	8.76B	13.19B	10.46B	10.86B	19.4B
Total Common Equity	134B	139B	143B	151B	172B
Minority Interest	1.21B	1.02B	1.49B	1.95B	2.44B
Total Equity	135B	140B	144B	153B	175B
Total Liabilities And Equity	236B	245B	245B	253B	282B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	110M	100M	97.74M	94.65M	94.64M
ECS Total Common Shares Outstanding	110M	100M	97.74M	94.65M	94.64M
Book Value / Share	1.22K	1.38K	1.46K	1.59K	1.82K
Tangible Book Value	131B	135B	137B	146B	166B
Tangible Book Value Per Share	1.19K	1.35K	1.4K	1.54K	1.76K
Total Debt	22.14B	21.72B	21.59B	21.16B	20.86B
Net Debt	-10.96B	-23.45B	-18.36B	-17.87B	-18.31B
Debt Equivalent of Unfunded Proj. Benefit Obligation	14.81B	14.98B	14.96B	14.24B	13.12B
Debt Equivalent Oper. Leases	72.34B	70.09B	62.91B	72.45B	71.11B
Minority Interest, Total (Incl. Fin. Div)	1.21B	1.02B	1.49B	1.95B	2.44B
Inventories - Raw Materials, Total	4.62B	4.47B	5.1B	5.89B	6.25B
Inventories - Work In Process, Total	1.59B	1.51B	5.83B	5.3B	6.49B
Inventories - Finished Goods, Total	11.92B	8.82B	9.72B	9.97B	8.6B
Full Time Employees	5.14K	5.2K	5.41K	5.49K	5.49K
Accumulated Allowance for Doubtful Accounts (Supple)	28M	27M	155M	157M	173M
Order Backlog	-	-	-	-	-

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	14.48B	18.01B	21.67B	23.15B	29.56B
Depreciation & Amortization - CF	5.93B	6B	5.74B	6.21B	6.53B
Depreciation & Amortization, Total	5.93B	6B	5.74B	6.21B	6.53B
(Gain) Loss From Sale Of Asset	17M	-112M	353M	515M	202M
(Gain) Loss on Sale of Investments - (CF)	130M	-2.34B	-3.9B	-4.34B	-3.37B
(Income) Loss On Equity Investments - (CF)	-360M	-193M	-395M	-469M	-510M
Other Operating Activities, Total	-4.32B	-4.32B	-5.04B	-8.14B	-8.1B
Change In Accounts Receivable	-6.26B	4.75B	-4.79B	-4.6B	-7.86B
Change In Inventories	1.12B	3.33B	-3.27B	-498M	-184M
Change In Accounts Payable	3.22B	1.85B	-6.79B	469M	2.66B
Change in Other Net Operating Assets	529M	-51M	1.74B	1.19B	2.41B
Cash from Operations	14.5B	26.92B	5.33B	13.49B	21.35B
Capital Expenditure	-5.08B	-4.74B	-5.24B	-12.37B	-15.77B
Sale of Property, Plant, and Equipment	444M	651M	329M	278M	263M
Cash Acquisitions	-	-	-2.46B	-	-
Sale (Purchase) of Intangible assets	-1.22B	-1.03B	-820M	-1.01B	-1.29B
Investment in Marketable and Equity Securities, Total	763M	4.09B	5.67B	6.45B	4.13B
Other Investing Activities, Total	-568M	201M	255M	-6M	414M
Cash from Investing	-5.66B	-833M	-2.26B	-6.66B	-12.25B
Short Term Debt Issued, Total	-	-	-	212M	-
Long-Term Debt Issued, Total	5.2B	2.11B	1.3B	5.3B	1.02B
Total Debt Issued	5.2B	2.11B	1.3B	5.51B	1.02B
Short Term Debt Repaid, Total	-4.92B	-131M	-87M	-	-165M
Long-Term Debt Repaid, Total	-663M	-2.39B	-1.7B	-6.02B	-1.19B
Total Debt Repaid	-5.59B	-2.52B	-1.79B	-6.02B	-1.36B
Repurchase of Common Stock	-	-8.83B	-3.53B	-4.07B	-1M
Common & Preferred Stock Dividends Paid	-3.31B	-3.09B	-3.99B	-4.11B	-7.19B
Common & Preferred Stock Dividends Paid	-3.31B	-3.09B	-3.99B	-4.11B	-7.19B
Other Financing Activities, Total	-693M	-742M	-592M	-794M	-666M
Cash from Financing	-4.39B	-13.07B	-8.6B	-9.48B	-8.2B
Foreign Exchange Rate Adjustments	-46M	-91M	305M	406M	313M
Miscellaneous Cash Flow Adjustments	957M	-3M	-	61M	-
Net Change in Cash	5.36B	12.92B	-5.23B	-2.19B	1.22B
Supplemental Items
Cash Interest Paid	162M	163M	156M	182M	152M
Cash Income Tax Paid (Refund)	4.36B	4.27B	6.18B	7.58B	8.22B
Levered Free Cash Flow	6.35B	19.11B	-1.02B	-2.33B	2.94B
Unlevered Free Cash Flow	6.45B	19.21B	-924M	-2.22B	3.03B
Change In Net Working Capital	1.56B	-10.12B	10.59B	5.91B	1.46B
Net Debt Issued / Repaid	-386M	-414M	-490M	-510M	-339M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.6	3.68	4.07	4.36	5.62
Return on Total Capital	5.39	5.55	6.1	6.4	8.13
Return On Equity %	7.43	8.68	10.62	10.92	12.6
Return on Common Equity	7.46	8.77	10.66	10.84	12.55
Margin Analysis
Gross Profit Margin %	32.29	32.77	32	32.13	33.45
SG&A Margin	26.1	25.99	25.05	25	24.6
EBITDA Margin %	7.63	8.26	8.31	8.51	10.25
EBITA Margin %	5.29	5.8	6.12	6.27	8.06
EBIT Margin %	5.29	5.8	6.12	6.27	8.06
Income From Continuing Operations Margin %	3.9	4.89	5.77	5.85	6.92
Net Income Margin %	3.89	4.9	5.74	5.74	6.8
Net Avail. For Common Margin %	3.89	4.9	5.74	5.74	6.8
Normalized Net Income Margin	3.64	4.01	4.22	4.24	5.41
Levered Free Cash Flow Margin	2.51	7.82	-0.39	-0.84	0.99
Unlevered Free Cash Flow Margin	2.55	7.86	-0.35	-0.8	1.02
Asset Turnover
Asset Turnover	1.09	1.01	1.06	1.11	1.12
Fixed Assets Turnover	4.39	4.2	4.44	4.4	4.17
Receivables Turnover (Average Receivables)	3.71	3.53	3.85	3.9	3.86
Inventory Turnover (Average Inventory)	9.2	9.98	10.02	8.99	9.34
Short Term Liquidity
Current Ratio	1.85	1.87	1.88	2.07	1.9
Quick Ratio	1.55	1.62	1.55	1.69	1.58
Operating Cash Flow to Current Liabilities	0.22	0.39	0.08	0.2	0.28
Days Sales Outstanding (Average Receivables)	98.61	103.29	94.74	93.67	94.89
Days Outstanding Inventory (Average Inventory)	39.76	36.57	36.43	40.59	39.19
Average Days Payable Outstanding	90.41	99.78	84.97	78.46	76.79
Cash Conversion Cycle (Average Days)	47.96	40.08	46.19	55.8	57.29
Long Term Solvency
Total Debt/Equity	16.34	15.54	14.98	13.86	11.93
Total Debt / Total Capital	14.04	13.45	13.03	12.17	10.66
LT Debt/Equity	9.85	9.97	6.82	8.94	5.42
Long-Term Debt / Total Capital	8.46	8.63	5.93	7.85	4.84
Total Liabilities / Total Assets	42.67	43.06	41.26	39.62	38.04
EBIT / Interest Expense	82.15	86.97	105.78	96.52	157.11
EBITDA / Interest Expense	118.56	123.81	143.77	131.03	199.8
(EBITDA - Capex) / Interest Expense	87.39	94.71	109.09	62.32	96.75
Total Debt / EBITDA	1.15	1.08	0.99	0.9	0.68
Net Debt / EBITDA	-0.57	-1.16	-0.85	-0.76	-0.6
Total Debt / (EBITDA - Capex)	1.55	1.41	1.31	1.89	1.41
Net Debt / (EBITDA - Capex)	-0.77	-1.52	-1.11	-1.59	-1.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.12	-3.44	6.84	6.06	7.68
Gross Profit, 1 Yr. Growth %	3.58	-2	4.34	6.48	12.1
EBITDA, 1 Yr. Growth %	7.62	4.43	7.58	8.64	29.61
EBITA, 1 Yr. Growth %	7.83	5.86	12.68	8.76	38.36
EBIT, 1 Yr. Growth %	7.83	5.86	12.68	8.76	38.36
Earnings From Cont. Operations, 1 Yr. Growth %	-3.54	20.93	26.14	7.56	27.23
Net Income, 1 Yr. Growth %	-3.74	21.52	25.24	6.1	27.5
Normalized Net Income, 1 Yr. Growth %	6.41	6.32	12.44	6.66	37.34
Diluted EPS Before Extra, 1 Yr. Growth %	-3.74	25.79	34.44	7.86	31.34
Accounts Receivable, 1 Yr. Growth %	10.32	-6.63	2.94	6.75	10.69
Inventory, 1 Yr. Growth %	-5.12	-18.41	39.54	2.5	0.86
Net Property, Plant and Equip., 1 Yr. Growth %	1.62	0.25	2.18	11.48	15.7
Total Assets, 1 Yr. Growth %	3.08	3.87	-0.04	3.07	11.55
Tangible Book Value, 1 Yr. Growth %	3.62	3.72	1.26	6.17	14.36
Common Equity, 1 Yr. Growth %	3.35	3.33	2.79	5.7	14.33
Cash From Operations, 1 Yr. Growth %	53.22	85.65	-80.21	153.21	58.26
Capital Expenditures, 1 Yr. Growth %	-6.36	-6.65	10.42	136.18	27.48
Levered Free Cash Flow, 1 Yr. Growth %	99.55	201.18	-105.33	129.06	-226.01
Unlevered Free Cash Flow, 1 Yr. Growth %	95.98	198	-104.81	140.28	-236.71
Dividend Per Share, 1 Yr. Growth %	14.29	0	25	37.5	56.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.33	-0.7	1.57	6.45	6.87
Gross Profit, 2 Yr. CAGR %	3.85	0.75	1.12	5.4	9.25
EBITDA, 2 Yr. CAGR %	2.07	6.01	5.99	8.11	18.66
EBITA, 2 Yr. CAGR %	0.94	6.84	9.22	10.7	22.67
EBIT, 2 Yr. CAGR %	0.94	6.84	9.22	10.7	22.67
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.63	8	23.51	16.48	16.98
Net Income, 2 Yr. CAGR %	-4.58	8.15	23.36	15.27	16.31
Normalized Net Income, 2 Yr. CAGR %	2.5	6.37	9.34	9.51	21.03
Diluted EPS Before Extra, 2 Yr. CAGR %	-4.58	10.04	30.04	20.42	19.02
Accounts Receivable, 2 Yr. CAGR %	2.63	1.49	-1.96	4.83	8.7
Inventory, 2 Yr. CAGR %	1.22	-12.01	6.7	19.59	1.68
Net Property, Plant and Equip., 2 Yr. CAGR %	1.54	0.93	1.21	6.73	13.57
Total Assets, 2 Yr. CAGR %	0.12	3.47	1.9	1.5	7.23
Tangible Book Value, 2 Yr. CAGR %	3.78	3.67	2.48	3.69	10.19
Common Equity, 2 Yr. CAGR %	3.55	3.34	3.06	4.23	9.93
Cash From Operations, 2 Yr. CAGR %	9.66	68.66	-39.38	-29.21	100.18
Capital Expenditures, 2 Yr. CAGR %	9.46	-6.51	1.52	61.49	73.52
Levered Free Cash Flow, 2 Yr. CAGR %	-3.96	145.15	-59.94	-65.07	69.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.04	141.66	-62.15	-66.01	81.24
Dividend Per Share, 2 Yr. CAGR %	10.94	6.9	11.8	31.1	46.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.26	0.37	1.75	3.05	6.86
Gross Profit, 3 Yr. CAGR %	3.38	1.86	1.93	2.88	7.59
EBITDA, 3 Yr. CAGR %	4.21	2.85	6.53	6.87	14.85
EBITA, 3 Yr. CAGR %	4.26	2.55	8.75	9.07	19.25
EBIT, 3 Yr. CAGR %	4.26	2.55	8.75	9.07	19.25
Earnings From Cont. Operations, 3 Yr. CAGR %	5.69	3.23	13.74	17.94	19.96
Net Income, 3 Yr. CAGR %	5.9	3.43	13.57	17.32	19.21
Normalized Net Income, 3 Yr. CAGR %	4.97	3.76	8.35	8.44	18.1
Diluted EPS Before Extra, 3 Yr. CAGR %	5.9	4.63	17.64	22.18	23.96
Accounts Receivable, 3 Yr. CAGR %	3.56	-0.56	1.97	0.86	6.75
Inventory, 3 Yr. CAGR %	4.34	-5.8	2.61	5.28	12.99
Net Property, Plant and Equip., 3 Yr. CAGR %	1.07	1.11	1.35	4.53	9.64
Total Assets, 3 Yr. CAGR %	2.61	1.35	2.29	2.29	4.75
Tangible Book Value, 3 Yr. CAGR %	6.14	3.76	2.86	3.7	7.13
Common Equity, 3 Yr. CAGR %	5.71	3.48	3.16	3.93	7.5
Cash From Operations, 3 Yr. CAGR %	8.23	30.7	-17.43	-2.38	-7.44
Capital Expenditures, 3 Yr. CAGR %	-17.86	3.8	-1.17	34.52	49.25
Levered Free Cash Flow, 3 Yr. CAGR %	152.48	40.58	-31.59	-28.37	-46.42
Unlevered Free Cash Flow, 3 Yr. CAGR %	126.67	40	-34.51	-29.91	-45.94
Dividend Per Share, 3 Yr. CAGR %	10.06	7.17	12.62	19.79	39.03
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.84	0.3	1.98	2.76	3.77
Gross Profit, 5 Yr. CAGR %	4.68	1.74	2.47	3.27	4.8
EBITDA, 5 Yr. CAGR %	7.02	3.31	4.92	4.92	11.23
EBITA, 5 Yr. CAGR %	8.84	1.81	6.21	5.74	14.12
EBIT, 5 Yr. CAGR %	8.84	1.81	6.21	5.74	14.12
Earnings From Cont. Operations, 5 Yr. CAGR %	9.11	5.57	12.48	8.34	15.02
Net Income, 5 Yr. CAGR %	8.93	5.71	12.57	8.01	14.66
Normalized Net Income, 5 Yr. CAGR %	7.09	2.93	6.7	6.02	13.26
Diluted EPS Before Extra, 5 Yr. CAGR %	8.94	6.45	14.97	10.68	18.19
Accounts Receivable, 5 Yr. CAGR %	3.29	0.2	1.31	1.56	4.61
Inventory, 5 Yr. CAGR %	2.87	-0.42	5.28	3.64	2.24
Net Property, Plant and Equip., 5 Yr. CAGR %	2.95	2.55	1.13	3.32	6.07
Total Assets, 5 Yr. CAGR %	2.65	2.45	2.32	1.41	4.24
Tangible Book Value, 5 Yr. CAGR %	5.87	5.68	4.66	3.73	5.73
Common Equity, 5 Yr. CAGR %	5.41	5.14	4.64	3.78	5.81
Cash From Operations, 5 Yr. CAGR %	14.21	14.18	-14.17	2.27	17.67
Capital Expenditures, 5 Yr. CAGR %	-0.12	1.4	-10.6	23.87	23.78
Levered Free Cash Flow, 5 Yr. CAGR %	37.9	25.09	20.9	-19.45	-1.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.15	24.49	10.78	-20.53	-1.6
Dividend Per Share, 5 Yr. CAGR %	13.49	9.86	10.76	16.17	25.16